In:
Clinical Endocrinology, Wiley, Vol. 92, No. 4 ( 2020-04), p. 350-357
Abstract:
Polycystic ovary syndrome (PCOS) is associated with an increased prevalence of dysglycaemia, which includes impaired glucose tolerance and type 2 diabetes mellitus (T2DM). Patients with PCOS demonstrate abnormal patterns of steroid hormones. Here, we analyse the correlation between glucose metabolism and serum steroid hormones in PCOS. Design Observational double‐centre study. Patients 914 patients with PCOS. Measurements We assessed the glucose metabolism status of all patients according to the 1999 WHO criteria. Serum steroid hormones were measured by liquid chromatography‐tandem mass spectrometry. Results The median age of the patients was 26 years (interquartile range: 21‐30), and 40.6% (371/914) had abnormal glucose metabolism: 29.3% (268/914) had prediabetes, and 11.3% (103/914) had T2DM. Correlation analysis not adjusting for confounding factors revealed that serum aldosterone, androstenedione, oestrone, pregnenolone and the free androgen index were positively correlated, while progesterone was negatively correlated with the risk of abnormal glucose metabolism. After adjusting for age, body mass index and fasting insulin levels in the logistic regression model, only aldosterone ( P = .013), androstenedione ( P = .046) and oestrone ( P = .014; in quartiles) were correlated with the risk of abnormal glucose metabolism. Conclusions This study indicates a high prevalence of prediabetes and T2DM in patients with PCOS. Furthermore, there were positive correlations of serum aldosterone, androstenedione and oestrone with the risk of abnormal glucose metabolism after adjusting for confounding factors.
Type of Medium:
Online Resource
ISSN:
0300-0664
,
1365-2265
Language:
English
Publisher:
Wiley
Publication Date:
2020
detail.hit.zdb_id:
2004597-9
